ask="7.20"
ask_size="700"
average_daily_volume="41995"
bid="4.02"
bid_size="100"
book_value="5.08"
change="+0.42"
change_from_200_day_moving_average="-0.65"
change_from_50_day_moving_average="-0.38"
change_from_52_week_high="-7.76"
change_From_52_week_low="1.10"
change_in_percent="+9.19%"
close="4.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.45"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.24"
high_52_weeks="12.75"
last_trade_date="1/4/2017"
last_trade_price="4.99"
last_trade_size="462"
last_trade_time="4:00pm"
low="4.57"
low_52_weeks="3.89"
market_capitalization="67.02M"
moving_average_200_day="5.64"
moving_average_50_day="5.37"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="16.33"
open="4.62"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.51%"
percent_change_from_50_day_moving_average="-7.07%"
percent_change_from_52_week_high="-60.86%"
percent_change_from_52_week_low="+28.28%"
previous_close="4.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.90"
price_per_sales="12.36"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.21"
stock_exchange="NGM"
symbol="AGLE"
volume="23197"
weeks_range_52="3.89 - 12.75"
